171 related articles for article (PubMed ID: 37744383)
1. β-CATENIN stabilizes HIF2 through lncRNA and inhibits intravenous immunoglobulin immunotherapy.
Nakagawa C; Kadlera Nagaraj M; Hernandez JC; Uthay Kumar DB; Shukla V; Machida R; Schüttrumpf J; Sher L; Farci P; Mishra L; Tahara SM; Ou JJ; Machida K
Front Immunol; 2023; 14():1204907. PubMed ID: 37744383
[TBL] [Abstract][Full Text] [Related]
2. Linc00210 drives Wnt/β-catenin signaling activation and liver tumor progression through CTNNBIP1-dependent manner.
Fu X; Zhu X; Qin F; Zhang Y; Lin J; Ding Y; Yang Z; Shang Y; Wang L; Zhang Q; Gao Q
Mol Cancer; 2018 Mar; 17(1):73. PubMed ID: 29540185
[TBL] [Abstract][Full Text] [Related]
3. LncTIC1 interacts with β-catenin to drive liver TIC self-renewal and liver tumorigenesis.
Chen Z; Yao L; Liu Y; Zhu P
Cancer Lett; 2018 Aug; 430():88-96. PubMed ID: 29778568
[TBL] [Abstract][Full Text] [Related]
4. High-dose hepatitis B immunoglobulin therapy in hepatocellular carcinoma with hepatitis B virus-DNA/hepatitis B e antigen-positive patients after living donor liver transplantation.
Lee EC; Kim SH; Lee SD; Park H; Lee SA; Park SJ
World J Gastroenterol; 2016 Apr; 22(14):3803-12. PubMed ID: 27076765
[TBL] [Abstract][Full Text] [Related]
5. lnc-β-Catm elicits EZH2-dependent β-catenin stabilization and sustains liver CSC self-renewal.
Zhu P; Wang Y; Huang G; Ye B; Liu B; Wu J; Du Y; He L; Fan Z
Nat Struct Mol Biol; 2016 Jul; 23(7):631-9. PubMed ID: 27239797
[TBL] [Abstract][Full Text] [Related]
6. LncFZD6 initiates Wnt/β-catenin and liver TIC self-renewal through BRG1-mediated FZD6 transcriptional activation.
Chen Z; Gao Y; Yao L; Liu Y; Huang L; Yan Z; Zhao W; Zhu P; Weng H
Oncogene; 2018 Jun; 37(23):3098-3112. PubMed ID: 29535420
[TBL] [Abstract][Full Text] [Related]
7.
Li X; Li M; Chen J; Dai H; Wang L; Xiong Y; Zhong Y; Zhang L
Oncotarget; 2017 Nov; 8(61):103785-103796. PubMed ID: 29262600
[TBL] [Abstract][Full Text] [Related]
8. Prevention and risk factors of hepatitis B recurrence after living donor liver transplantation.
Na GH; Kim DG; Han JH; Kim EY; Lee SH; Hong TH; You YK; Choi JY
J Gastroenterol Hepatol; 2014 Jan; 29(1):151-6. PubMed ID: 24117684
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B virus X protein promotes the stem-like properties of OV6
Wang C; Wang MD; Cheng P; Huang H; Dong W; Zhang WW; Li PP; Lin C; Pan ZY; Wu MC; Zhou WP
Cell Death Dis; 2017 Jan; 8(1):e2560. PubMed ID: 28102846
[TBL] [Abstract][Full Text] [Related]
10. LncAPC drives Wnt/β-catenin activation and liver TIC self-renewal through EZH2 mediated APC transcriptional inhibition.
Fu X; Lin J; Qin F; Yang Z; Ding Y; Zhang Y; Han L; Zhu X; Zhang Q
Mol Carcinog; 2018 Mar; 57(3):408-418. PubMed ID: 29144570
[TBL] [Abstract][Full Text] [Related]
11. LncRNA NUTM2A-AS1 aggravates the progression of hepatocellular carcinoma by activating the miR-186-5p/KLF7-mediated Wnt/beta-catenin pathway.
Long J; Liu L; Yang X; Zhou X; Lu X; Qin L
Hum Cell; 2023 Jan; 36(1):312-328. PubMed ID: 36242728
[TBL] [Abstract][Full Text] [Related]
12. Low-dose anti-hepatitis B immunoglobulin regimen as prophylaxis for hepatitis B recurrence after liver transplantation.
Lee WC; Chou HS; Wu TH; Cheng CH; Lee CF; Wang YC; Wu TJ; Chan KM
Transpl Infect Dis; 2019 Dec; 21(6):e13190. PubMed ID: 31587427
[TBL] [Abstract][Full Text] [Related]
13. Prevention of hepatitis B recurrence after living donor liver transplantation: primary high-dose hepatitis B immunoglobulin monotherapy and rescue antiviral therapy.
Hwang S; Lee SG; Ahn CS; Kim KH; Moon DB; Ha TY; Song GW; Jung DH; Park JI; Ryu JH; Lee HJ; Suh DJ; Lim YS
Liver Transpl; 2008 Jun; 14(6):770-8. PubMed ID: 18508369
[TBL] [Abstract][Full Text] [Related]
14. Does the hepatitis B antigen HBx promote the appearance of liver cancer stem cells?
Arzumanyan A; Friedman T; Ng IO; Clayton MM; Lian Z; Feitelson MA
Cancer Res; 2011 May; 71(10):3701-8. PubMed ID: 21464043
[TBL] [Abstract][Full Text] [Related]
15. rtcisE2F promotes the self-renewal and metastasis of liver tumor-initiating cells via N
Chen Z; Huang L; Wang K; Zhang L; Zhong X; Yan Z; Liu B; Zhu P
Sci China Life Sci; 2022 Sep; 65(9):1840-1854. PubMed ID: 35266112
[TBL] [Abstract][Full Text] [Related]
16. LncHOXA10 drives liver TICs self-renewal and tumorigenesis via HOXA10 transcription activation.
Shao M; Yang Q; Zhu W; Jin H; Wang J; Song J; Kong Y; Lv X
Mol Cancer; 2018 Dec; 17(1):173. PubMed ID: 30545354
[TBL] [Abstract][Full Text] [Related]
17. HBx mutations promote hepatoma cell migration through the Wnt/β-catenin signaling pathway.
Chen Z; Tang J; Cai X; Huang Y; Gao Q; Liang L; Tian L; Yang Y; Zheng Y; Hu Y; Tang N
Cancer Sci; 2016 Oct; 107(10):1380-1389. PubMed ID: 27420729
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of CREB binding protein-beta-catenin signaling down regulates CD133 expression and activates PP2A-PTEN signaling in tumor initiating liver cancer cells.
Tang Y; Berlind J; Mavila N
Cell Commun Signal; 2018 Mar; 16(1):9. PubMed ID: 29530069
[TBL] [Abstract][Full Text] [Related]
19. Targeting Jak/Stat pathway as a therapeutic strategy against SP/CD44+ tumorigenic cells in Akt/β-catenin-driven hepatocellular carcinoma.
Toh TB; Lim JJ; Hooi L; Rashid MBMA; Chow EK
J Hepatol; 2020 Jan; 72(1):104-118. PubMed ID: 31541681
[TBL] [Abstract][Full Text] [Related]
20. Cripto-1 contributes to stemness in hepatocellular carcinoma by stabilizing Dishevelled-3 and activating Wnt/β-catenin pathway.
Lo RC; Leung CO; Chan KK; Ho DW; Wong CM; Lee TK; Ng IO
Cell Death Differ; 2018 Aug; 25(8):1426-1441. PubMed ID: 29445127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]